SNAP-8
⚠️ Structural Separation Notice
The Ageless Pep Academy is a clinical education property independent from any commerce operation. Any references in this profile to Ageless Peps product SKUs, pricing, or the agelesspeps.com domain are for completeness and transparency; they are not endorsements and do not form part of the clinical education content. Clinicians are responsible for independent verification of any product sourcing decision. The Academy's Medical Director provides editorial oversight only and does not endorse commercial products.
Cosmetic octapeptide (Acetyl Octapeptide-3) that competitively inhibits SNARE complex formation to reduce neuromuscular junction signaling, decreasing dynamic wrinkle depth — an elongated, potentially more potent version of Argireline.
Quick Facts
| Property | Value |
|---|---|
| Also Known As | Acetyl Octapeptide-3, Acetyl Octapeptide-1, SNAP-8 Peptide, Lipotec SNAP-8 |
| Category | Cosmetic / Topical / Neurotransmitter Inhibitor Peptide |
| Sequence | Acetyl-Glu-Glu-Met-Gln-Arg-Arg-Ala-Asp-NH2 (octapeptide; N-acetylated) |
| Molecular Weight | ~1075 Da |
| Molecular Formula | C41H68N16O16S |
| PubChem CID | 71587832 |
| Administration | Topical |
| Typical Dose Range | 3-10% in finished formulation |
| Half-Life | N/A (topical, local action) |
| Storage | 2-8C for bulk; room temperature in finished product; protect from light |
| FDA Status | Cosmetic ingredient (INCI listed); NOT a drug — no FDA approval required or sought |
| WADA Status | Not applicable |
Mechanism of Action
SNAP-8 works through the same fundamental mechanism as its parent compound Argireline (Acetyl Hexapeptide-3): competitive inhibition of the SNARE (Soluble N-ethylmaleimide-sensitive factor Attachment protein REceptor) complex. The SNARE complex is a molecular machine essential for synaptic vesicle fusion and neurotransmitter release at the neuromuscular junction.
Under normal physiology, three proteins — SNAP-25 (synaptosomal-associated protein 25 kDa), VAMP/synaptobrevin, and syntaxin — assemble into the SNARE complex, driving vesicle fusion and acetylcholine (ACh) release. Botulinum toxin (Botox) works by cleaving SNAP-25, permanently disabling this machinery. SNAP-8 takes a different approach: its amino acid sequence mimics the N-terminal domain of SNAP-25, allowing it to competitively bind into the SNARE complex and interfere with its assembly. This reduces — but does not eliminate — acetylcholine release at facial neuromuscular junctions, resulting in decreased muscle contraction amplitude and reduced dynamic wrinkle formation (PMID: 33195061).
SNAP-8 is an 8-amino acid elongation of the 6-amino acid Argireline sequence. The additional two residues (Ala-Asp) at the C-terminus are proposed to improve binding affinity to the SNARE complex, potentially increasing potency. In manufacturer-sponsored testing, SNAP-8 at 3% of a 0.05% solution reduced wrinkle depth by up to 38% over 28 days of twice-daily application, with an average reduction of 7.1% (PMID: 33195061).
The key limitation of all topical neurotransmitter-inhibiting peptides, including SNAP-8, is penetration through the stratum corneum. SNAP-8 is hydrophilic and relatively large (~1075 Da), making passive diffusion through the lipophilic skin barrier challenging. Effective delivery requires formulation strategies such as oil-in-water emulsions, microneedle patches, nanoparticle carriers, or penetration enhancers (PMID: 39082657).
Key Research Areas
- Anti-wrinkle efficacy — Split-face studies show up to 38% wrinkle depth reduction with topical SNAP-8 formulations applied twice daily for 28 days (PMID: 33195061)
- SNARE complex inhibition — Competitive binding to SNAP-25 binding site reduces acetylcholine vesicle fusion and release, mimicking Botox mechanism non-invasively
- Advanced delivery systems — Dissolving microneedle patches containing SNAP-8 demonstrate improved penetration and clinical anti-wrinkle efficacy (PMID: 39082657)
- Comparison to Argireline — Elongated 8-amino acid sequence vs. 6-amino acid Argireline; potentially improved SNARE complex binding affinity
Evidence Level Summary
| Evidence Type | Count | Notes |
|---|---|---|
| Human RCTs | 1 | Microneedle delivery split-face RCT (n=24) |
| Human observational | 0 | — |
| Animal in vivo | 0 | — |
| In vitro | 1+ | SNARE complex binding, skin penetration studies |
| Systematic reviews | 0 | None specific to SNAP-8 |
| Narrative reviews | 1 | Cosmeceutical peptides review covering SNAP-8 mechanism and efficacy |
Clinical Applications
- Skin Health — Dynamic wrinkle reduction (expression lines)
- Anti-Aging — Non-invasive alternative to botulinum toxin for facial aging
Protocols Using This Peptide
- Skin Rejuvenation Protocol — Topical anti-wrinkle component
Ageless Peps Products
- AP-SNAP8-Vial — SNAP-8 vial (WC ID 772, DRAFT — not yet published, $120)
Dosing Reference
Research Dosing Ranges (from literature)
| Route | Dose Range | Frequency | Duration | Source |
|---|---|---|---|---|
| Topical | 3-10% in formulation | Twice daily | 28+ days | PMID 33195061 |
| Microneedle patch | As formulated in HA backbone | Overnight application | 28 days | PMID 39082657 |
Cycling
No cycling required. Continuous daily use is recommended. Effects are reversible and cease within weeks of discontinuation (similar to Argireline).
Contraindications & Safety
- Contraindications: Known hypersensitivity to any component
- Common side effects: Rare mild skin irritation at higher concentrations; patch test recommended at 10%
- Drug interactions: No systemic absorption at cosmetic concentrations; no known interactions
- Pregnancy/nursing: Topical peptides generally considered safe at cosmetic concentrations; consult dermatologist
- Special populations: Well-tolerated across skin types; limited data in pediatric populations (not indicated)
Synergistic Combinations
- Argireline + SNAP-8 — Parent and elongated form; can be combined for enhanced SNARE inhibition, though mechanism overlap means diminishing returns
- Syn-ake + SNAP-8 — Complementary mechanisms: SNAP-8 inhibits SNARE complex (presynaptic), Syn-ake blocks nicotinic acetylcholine receptor (postsynaptic). Dual blockade of neuromuscular signaling
- Matrixyl + SNAP-8 — SNARE inhibition (muscle relaxation) + collagen stimulation (ECM repair) for comprehensive anti-aging
- GHK-Cu + SNAP-8 — Copper peptide remodeling + muscle relaxation for synergistic wrinkle reduction
Related Research
| PMID | Title | Year | Study Type |
|---|---|---|---|
| 33195061 | Cosmeceutical Peptides in the Framework of Sustainable Wellness Economy | 2020 | Narrative Review |
| 39082657 | Dissolving Microneedle Patch with Acetyl Octapeptide-3: Clinical Anti-Wrinkle Evaluation | 2024 | RCT |
References
- PMID 33195061 — Comprehensive cosmeceutical peptide review including SNAP-8 mechanism and efficacy data
- PMID 39082657 — Clinical microneedle delivery study with SNAP-8
Related
- Peptide Index
- Condition Index
- Protocol Index
- Argireline — Parent compound (Acetyl Hexapeptide-3, 6 amino acids vs. SNAP-8's 8)
- Syn-ake — Complementary anti-wrinkle mechanism (postsynaptic blockade)
- Matrixyl — Signal peptide for collagen stimulation
#peptide #cosmetic #topical